Published by Wanda Rich
Posted on April 23, 2025
According to a recent Fact.MR report, the global endoscopy ultrasound market is forecast to reach US$ 1.85 Billion by the end of the 2022-2032 forecast period, registering a CAGR of 5.7%. By 2022, the market is poised to reach a valuation of US$ 1.06 Billion. The scope of the worldwide endoscopy ultrasound market has expanded, mostly due to an increase in the global incidence of gastrointestinal malignancies.
From 2015 to 2021, sales of endoscopy ultrasound products have risen significantly, documenting a CAGR of 4.8% to be valued at US$ 997 million. The World Health Organization (WHO) estimates that stomach malignancies account for more than 700,000 cancer-related deaths. As a result, the use of endoscopy ultrasound techniques has grown in importance.
As a result of the COVID-19 pandemic, healthcare personnel postponed elective endoscopic ultrasonography treatments to limit transmission from infected patients to healthcare staff. This limits growth prospects to a minor extent. Endoscopy ultrasound methods are less expensive than procedures like Endoscopic Retrograde Cholangiopancreatography (ERCP), which will drive market expansion.
Click to Request a Sample of this Report for Additional Market Insights:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4689
Key Takeaways from the Market Study:
"The global endoscopy ultrasound market is expanding at a rapid pace." The increasing frequency of gastrointestinal and pancreatic malignancies is expected to fuel market expansion. As a result, key market players are focusing on technical innovations in order to produce higher-quality goods and solutions," says a Fact.MR Analyst.
Expanding Applications Propel Growth in the Endoscopy Ultrasound Market
The increasing use of endoscopic ultrasound (EUS) across a range of clinical applications is playing a pivotal role in driving global market growth. EUS has become a critical diagnostic tool in identifying gastrointestinal cancers, particularly pancreatic and liver cancers. The growing prevalence of these conditions is contributing significantly to the demand for EUS-related products, including endoscopes, probes, and fine-needle aspiration systems.
According to the American Cancer Society, an estimated 62,210 individuals in the United States were expected to be diagnosed with pancreatic cancer in 2022, with approximately 49,830 deaths anticipated due to the disease. Pancreatic cancer accounts for around 3% of all cancers and about 7% of all cancer-related deaths in the country, impacting men slightly more than women. Additionally, the GLOBOCAN 2020 study reported that liver cancer ranks as the fourth most prevalent cancer in Asia, representing over 70% of all new liver cancer cases globally.
This surge in cancer incidence, coupled with the launch of novel EUS technologies and devices, continues to stimulate innovation within the market. Leading companies are developing sophisticated tools that enhance procedural accuracy and enable broader application of EUS techniques. Beyond oncology, the adoption of EUS is expanding into other medical domains, further reinforcing its importance as a versatile diagnostic solution.
Innovations such as electrography and contrast-enhanced endoscopic ultrasound (CE-EUS) are gaining popularity, offering enhanced visualization and improved diagnostic capabilities. These advanced modalities are creating new opportunities and setting the stage for continued market expansion between 2022 and 2032.
Technological Breakthroughs to Accelerate Endoscopy Ultrasound Market Expansion
Alongside the growing clinical adoption of EUS, continuous technological advancements in healthcare are strengthening the outlook for the global endoscopy ultrasound market. Although much attention has recently been directed at robotics and minimally invasive procedures in urology and gynecology, the field of endoscopic imaging is also undergoing significant transformation.
Innovative technologies such as high-intensity focused ultrasound (HIFU) are beginning to emerge as potential game-changers, while refined imaging techniques are enhancing the precision of diagnostics and therapeutic interventions. Endoscopic ultrasonography, in particular, is drawing increasing interest as it provides critical insights into internal structures with greater clarity and minimal invasiveness.
As the medical community continues to invest in cutting-edge imaging solutions and precision medicine, endoscopic ultrasound is poised to benefit from this wave of innovation. Healthcare providers are embracing these developments not only to improve patient outcomes but also to reduce procedural risks and recovery times.
Overall, the combination of rising cancer prevalence, technological progress, and the widening scope of EUS applications is expected to drive robust growth in the endoscopy ultrasound market throughout the next decade.
Get a Custom Analysis for Targeted Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=4689
Competitive Landscape
Three major companies lead the worldwide endoscopy ultrasound market: Olympus Corporation, PENTAX Medical (HOYA Corporation), and FUJIFILM Corporation. These businesses are continually improving their technology in order to deliver superior solutions to their customers. These companies are pursuing organic and inorganic growth strategies in order to broaden their product offerings, extend their geographical reach, and increase their market share in the worldwide endoscopy ultrasound market.
More Valuable Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the endoscopy ultrasound, presenting historical demand data (2015-2021) and forecast statistics from 2022 to 2032.
The study divulges essential insights into the market based on product (endoscope, ultrasound probe, ultrasonic processor, imaging systems, needles and accessories), procedure (upper EUS, lower EUS, EUS guided fine-needle aspiration and others), technology (radial scanning and linear scanning), application (oncology, upper GI oncology, lower GI oncology, pancreatic conditions and others), and end user (hospitals, specialty clinics, ambulatory surgery centers and diagnostic centers) across five major regions (North America, Latin America, Europe, Asia Pacific, Latin America and Middle East & Africa).
Explore More Related Studies Published by Fact.MR Research:
The global ambulance cot market size is projected to advance at a CAGR of 3.7% and reach US$ 1.13 billion by the end of 2034.
Americas hospital acquired infection testing industry analysis predicts the market to attain a valuation of US$ 2.7 Bn by the end of the decade, which is more than 4X more than its worth at present.
As per a new study by seasoned analysts at Fact.MR, the global aquaculture feed and pharmaceutical market size is pegged at US$ 999.4 million for 2024.
The global natural cold, cough, and sore throat remedies market accounts for a revenue of US$ 6.15 billion in 2023 and is predicted to secure a valuation of US$ 11.55 billion by the end of 2033.
The global ankle syndesmosis treatment device marketis estimated at US$ 184.8 million in 2024. Worldwide sales of ankle syndesmosis treatment devices are forecasted to rise at 7.9% CAGR and reach US$ 396.7 million by the end of 2034.
The global antibiotic residue test kits market size is currently being valued at US$ 184.5 million in 2023, and is projected to reach US$ 333.4 million by 2033-end, growing at a CAGR of 6.1% during the forecast period from 2023 to 2033.
The global aortic stenosis treatment market size has been forecasted to expand at a CAGR of 9.7% and climb to a value of US$ 19.09 billion by 2034.
